Markets:

Overview

News

Currencies

International

Treasuries

Longeveron Inc. - Class A Common stock (NQ:LGVN)

0.5780 +0.0293 (+5.34%)

Streaming Delayed Price Updated: 12:46 PM EST, Jan 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Longeveron Inc. - Class A Common stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 24, 2022

Via Benzinga

Longeveron: Q2 Earnings Insights ↗

August 12, 2022

Longeveron (NASDAQ:LGVN) reported its Q2 earnings results on Friday, August 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For August 12, 2022 ↗

August 12, 2022

Companies Reporting Before The Bell • NeoGenomics (NASDAQ:NEO) is projected to report quarterly earnings at $0.44 per share on revenue of $218.26 million.

Via Benzinga

Longeveron Earnings Preview ↗

August 11, 2022

Longeveron (NASDAQ:LGVN) is set to give its latest quarterly earnings report on Friday, 2022-08-12. Here's what investors need to know before the announcement. Analysts estimate that Longeveron will...

Via Benzinga

Recap: Longeveron Q1 Earnings ↗

May 13, 2022

Longeveron (NASDAQ:LGVN) reported its Q1 earnings results on Friday, May 13, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Is This Company In A Special Position Even As The COVID-19 Pandemic Affects Cell-Based Therapy Industry? ↗

August 09, 2022

According to Grand View Research, the global cell therapy market was valued at $7.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 14.5% between 2021 and 2028.

Via Benzinga

Publication Of Peer-Reviewed Study In Journal Of The Alzheimer's Association Could Mark A Significant Step For Longeveron ↗

August 02, 2022

Recent publishing of Longeveron Inc.’s (NASDAQ: LGVN)

Via Benzinga

Aging Veterans May Have New Options As VA And Longeveron Make Progress On Clinical Research Of Aging Frailty Treatment ↗

July 28, 2022

The U.S. Department of Veterans Affairs (VA) partnered with Longeveron Inc. (NASDAQ: LGVN) to explore the clinical-stage biotech’s novel cell therapies as a potential treatment for aging frailty.

Via Benzinga

7 Moonshot Investments Upending a $10 Trillion Industry ↗

July 08, 2022

Gene editing is expensive at an estimated $5 billion per drug, but it could change the world in the very near future.

Via InvestorPlace

This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday ↗

July 08, 2022

Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market.

Via Benzinga

Why U.S. Stocks Are Trading Higher After Rise In Jobless Claims ↗

July 07, 2022

U.S. stocks traded higher this morning, following the release of data on initial jobless claims.

Via Benzinga

This EV Maker Stock Jumps More Than 9%, Here's 46 Stocks Moving In Thursday's Mid-Day Session ↗

July 07, 2022

Gainers United Maritime Corporation (NASDAQ: USEA) jumped 180.4% to $8.02. The company’s stock jumped 190% on Wednesday after completing its spin-off from Seanergy Maritime Holdings Corp.

Via Benzinga

7 Ways to Prepare for a Recession: An Investor’s Guide ↗

June 24, 2022

There are plenty of ways to prepare for a recession. Here are seven ways you can make sure you're ready for whatever comes next.

Via InvestorPlace

Should Aging Be Treated As A Disease? And How One Company Might Be Shifting The Paradigm To Reverse It ↗

June 15, 2022

Technical advancements in stem cell therapies have reportedly shifted the outlook of regenerative medicine, and some scientists are getting increasingly excited.

Via Benzinga

How to Buy Stocks in a Recession ↗

May 16, 2022

The same strategies for buying stocks during a bull market don't apply during a recession. Learn what you need to do going forward.

Via InvestorPlace

The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product ↗

May 13, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Earnings Scheduled For May 13, 2022 ↗

May 13, 2022

Companies Reporting Before The Bell • Codere Online Luxembourg (NASDAQ:CDRO) is estimated to report quarterly loss at $0.13 per share on revenue of $20.08 million.

Via Benzinga

Longeveron's Earnings: A Preview ↗

May 12, 2022

Longeveron (NASDAQ:LGVN) is set to give its latest quarterly earnings report on Friday, 2022-05-13. Here's what investors need to know before the announcement. Analysts estimate that Longeveron will...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

May 12, 2022

With the start of another day comes our breakdown of the biggest pre-market stock movers and this time it's for Thursday!

Via InvestorPlace

The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves ↗

May 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Follow the Insiders and Buy the Dip in These 3 Stocks ↗

May 06, 2022

These three biotech companies have all had insiders buying shares recently. That's a good sign for the future of their treatments.

Via InvestorPlace

Analyzing Longeveron Inc. - common stock's Short Interest ↗

April 19, 2022

Longeveron Inc. - common stock's (NASDAQ:LGVN) short percent of float has risen 35.04% since its last report. The company recently reported that it has 746.20 thousand shares sold...

Via Benzinga

71 Biggest Movers From Yesterday ↗

April 27, 2022

Gainers Evoke Pharma, Inc. (NASDAQ: EVOK) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product exclusivity to Evoke Pharma's Gimoti (...

Via Benzinga

Longeveron Partners With US Department Of Veterans Affairs For Its Phase 2 Alzheimer's Trial ↗

April 18, 2022

Photo by Caleb Fisher on Unsplash

Via Benzinga

53 Biggest Movers From Yesterday ↗

April 21, 2022

Gainers ION Geophysical Corporation (NYSE: IO) shares surged 91.2% to settle at $0.6980 on Wednesday. ION Geophysical was awarded a five-year contract by Brunei Shell Petroleum...

Via Benzinga

Cognitive Drugs Market Expected Reach Revenues Of $21 Billion in 2027

April 13, 2022

Palm Beach, FL – April 13, 2022 – FinancialNewsMedia.com News Commentary – Dementia is the loss of cognitive functioning, thinking, remembering, reasoning, and behavioral abilities to such an extent...

Via FinancialNewsMedia

EXCLUSIVE: Longeveron Adds Miami Veterans Affairs Site To Its Ongoing Mid-Stage Alzheimer's Trial ↗

April 13, 2022

Longeveron Inc (NASDAQ: LGVN) has announced a Cooperative Research and Development Agreement (CRADA) with the United States Department of Veterans Affairs (VA) to add Miami VA clinical site to its...

Via Benzinga

5 Short Squeeze Candidates To Watch: Aterian Tops The List, System1 Group And Longeveron Join Leaderboard ↗

April 11, 2022

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value...

Via Benzinga

Recession Fears are Creating a Golden Opportunity for Biotech Stocks ↗

April 08, 2022

Biotech stocks are hard for novice investors to successfully profit from, but it's worth your time to learn the techniques now.

Via InvestorPlace

A Peek Into The Markets: US Stock Futures Down Ahead Of Fed Minutes ↗

April 06, 2022

Pre-open movers

Via Benzinga

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.